Document

0001179929-24-000037.txt : 20240214 0001179929-24-000037.hdr.sgml : 20240214 20240214163800 ACCESSION NUMBER: 0001179929-24-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keim Mark Lowell CENTRAL INDEX KEY: 0001690677 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31719 FILM NUMBER: 24639410 MAIL ADDRESS: STREET 1: 440 LINCOLN STREET STREET 2: E-6 CITY: WORCESTER STATE: MA ZIP: 01653 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOLINA HEALTHCARE, INC. CENTRAL INDEX KEY: 0001179929 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 134204626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 BUSINESS PHONE: 5624353666 MAIL ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 FORMER COMPANY: FORMER CONFORMED NAME: MOLINA HEALTHCARE INC DATE OF NAME CHANGE: 20020812 4 1 wk-form4_1707946664.xml FORM 4 X0508 4 2024-02-12 0 0001179929 MOLINA HEALTHCARE, INC. MOH 0001690677 Keim Mark Lowell 2180 HARVARD STREET SUITE 400 SACRAMENTO CA 95815 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-02-12 4 S 0 1264 388.614 D 50267 D Common Stock 2024-02-12 4 S 0 4251 387.938 D 46016 D Common Stock 2024-02-12 4 S 0 4351 387 D 41665 D Common Stock 2024-02-12 4 S 0 1203 385.795 D 40462 D Common Stock 2024-02-12 4 S 0 1815 384.578 D 38647 D Common Stock 2024-02-12 4 S 0 2116 383.821 D 36531 D Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020. Jeff D. Barlow, by power of attorney for Mark Lowell Keim 2024-02-14 EX-24 2 keimpoa.htm EX-24 Document

LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS

Know all by these presents that the undersigned hereby constitutes and

appoints Jeff D. Barlow and Codruta Boggs, and each acting singly, the

undersigned's true and lawful attorney-in-fact to:

1) execute for and on behalf of the undersigned, in the undersigned's

capacity as an officer, director and/or stockholder of Molina Healthcare,

Inc. (the "Company"), Forms 3, 4, and 5 and amendments thereto in

accordance with Section 16(a) of the Securities Exchange Act of 1934 and

the rules thereunder; and

2) do and perform any and all acts for and on behalf of the undersigned

which may be necessary or desirable to complete and execute any such Form

3, 4, or 5 or amendments thereto and timely file such form with the

United States Securities and Exchange Commission (the "SEC") and any stock

exchange or similar authority.

The undersigned hereby grants to each such attorney-in-fact full power

and authority to do and perform any and every act and thing whatsoever

requisite, necessary, or proper to be done in the exercise of any of the

rights and powers herein granted, as fully to all intents and purposes as

the undersigned might or could do if personally present, with full power

of substitution or revocation, hereby ratifying and confirming all that

such attorney-in-fact, or such attorney-in-fact's substitute or

substitutes, shall lawfully do or cause to be done by virtue of this

Power of Attorney and the rights and powers herein granted. The

undersigned acknowledges that the foregoing attorneys-in-fact, in serving

in such capacity at the request of the undersigned, are not assuming, nor

is the Company assuming, any of the undersigned's responsibilities to

comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms 3, 4, and 5 with respect

to the undersigned's holdings of and transaction in securities of the

Company, unless earlier revoked by the undersigned in a signed writing

delivered to the foregoing attorneys-in-fact. This Power of Attorney may

be filed with the SEC as a confirming statement of the authority granted

herein.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney

to be executed as of this 9th day of March 2018.

/s/ Mark Lowell Keim

Signature

Mark Lowell Keim

Printed Name